Co-occurring Disorders (2019) | Richard Ries, MD

This presentation is part of the Addiction Medicine Review Course 2019, an overview of the core elements of addiction medicine, presented by top experts in the field. Together with the other presentations it can serve as a broad review for clinicians, a review of the basics for newcomers, or a starting point for those preparing to sit for the ABPM Board Examination in Addiction Medicine. 

Learners cannot sign up for individual lectures, only for the full Addiction Medicine Review Course 2019. Please contact CSAM (csam@csam-asam.org) if you have any questions about this online educational offering. 

Target Audience

  • Addiction medicine specialists who want an overview of the latest developments in the field and their relevance to clinical practice
  • Primary care clinicians who want to get a better understanding of addiction and manage patients with addictions in their practice
  • Public health officials who want an understanding of the current state of addiction treatment
  • Non-physicians who are involved in the treatment of addiction

Learning Objectives

  1. Upon completion of this session, lerners will be able to apply the best strategies to differentiate Schizophrenic from Methamphetamine induced Psychoses
  2. Upon completion of this session, lerners will be able to apply clinical screening questions for both suicide and overdose risk
Course summary
Available credit: 
  • 0.75 AMA Category 1
  • 0.75 Attendance
Course opens: 
08/16/2019
Course expires: 
09/01/2022
Cost:
$0.00
Rating: 
0


Richard Ries, MD, DFASAM, FAPA

Dr. Richard Ries is Professor of Psychiatry at the University of Washington Medical School in Seattle, Washington. Dr. Ries serves as Director of the Addictions Division , Associate Director of the University of Washington Addiction Psychiatry Residency Program and works clinically at Harborview Medical Center. He has obtained NIDA sponsored clinical research grants on Co-occurring Disorders, including suicide and addictions. Dr. Ries was chosen to chair the first official Treatment Improvement Protocol (TIP#9-1994) on dual disorders and co-chaired its update TIP 42 by the Center for Substance Abuse Treatment. He was lead editor of the key reference text Principles of Addiction Medicine, editions 4 and 5, published by the American Society of Addiction Medicine.

Nothing to disclose.

CSAM 
The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.

CSAM designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credits™, Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Continuing education credit is available for psychologists, therapists, substance use counselors, nurses and physician assistants.

(see additional information on page for parent course)

Available Credit

  • 0.75 AMA Category 1
  • 0.75 Attendance

Accreditation Period

Course opens: 
08/16/2019
Course expires: 
09/01/2022

Price

Cost:
$0.00
Please login or register to take this course.